Showing posts from 2023

ChatGPT and Artificial Intelligence — Friend or Foe?

In a February 7, 2023, video report (below), investigative journalist Glenn Greenwald reviewed the promise, and threat, posed by ChatGPT, 1 , 2   the "latest and greatest" chatbot powered by artificial intelligence (AI). "GPT" stands for "generative pretrained transformer," and the "chat" indicates that it's a chatbot. The first GPT platform was created by OpenAI in 2018. The current version was released at the end of November 2022, and it took internet users by storm, acquiring more than 1 million users in the first five days. 3  Two months after its release, there were more than 30 million users. 4 ChatGPT uses "machine learning" — statistical pattern finding in huge datasets — to generate human-like responses in everyday language to any question asked of it. It basically works by predicting what the next word in a sentence ought to be based on previous examples found in the massive amounts of d

FLCCC I-Care Early Treatment Protocol (2023)

The Front Line COVID-19 Critical Care (FLCCC) Alliance was initially formed as a working group under “emergency” conditions of the early COVID-19 pandemic in response to multiple early reports of COVID patients with an inexplicably high need for prolonged mechanical ventilation and an excessive mortality associated with the prevailing “supportive care only” recommendations disseminated by the majority of national and international health care organizations. Early treatment is critical and the most important factor in managing this disease. COVID-19 is a clinical diagnosis; a confirmed antigen or PCR test is not required. Treatment should be initiated immediately after the onset of flu-like symptoms. The multiple therapies and drugs in this protocol have different mechanisms of action and work synergistically during various phases of the disease. About this Protocol The information in this document is our recommended approach to COVID-19 based on the best (and most recent) literature. I